{"id":2247,"date":"2017-12-19T16:49:20","date_gmt":"2017-12-19T16:49:20","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=33538"},"modified":"2017-12-19T16:49:20","modified_gmt":"2017-12-19T16:49:20","slug":"international-publications-spotlight-mjnas-influence-u-n-s-global-cbd-policy-announcement","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/12\/19\/international-publications-spotlight-mjnas-influence-u-n-s-global-cbd-policy-announcement\/","title":{"rendered":"International Publications Spotlight MJNA\u2019s Influence on U.N.\u2019s Global CBD Policy Announcement"},"content":{"rendered":"
Following the WHO\u2019s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA\u2019s role in the organization\u2019s decision.<\/span><\/i><\/p>\n Several international news publications covering last week\u2019s World Health Organization <\/span>announcement<\/span><\/a> of its recommendation that cannabidiol (<\/span>CBD<\/span><\/a>) not be subject to international drug scheduling specifically highlighted the impact of Medical Marijuana, Inc. Executive Raul Elizalde.<\/span><\/p>\n Raul, President of Medical Marijuana, Inc. subsidiary HempMeds\u00ae Mexico, was<\/span> invited to speak about CBD<\/span><\/a> at the WHO\u2019s Thirty-Ninth meeting of the Expert Committee on Drug Dependence in Geneva, Switzerland in November. The ECDD was reevaluating its international regulations of 16 substances, including CBD, a cannabis-derived, non-psychoactive compound that interacts with our naturally occurring systems.<\/span><\/p>\n On behalf of MJNA\u2019s family of companies, Raul spoke to the ECDD about the benefits of CBD and encouraged the special committee to classify the non-psychoactive compound as a nutritional supplement and food rather than a drug. The special committee\u2019s recommendation regarding the regulation of CBD is likely to have positive worldwide implications on legal access.<\/span><\/p>\n MJNA’s #RaulWHO campaign followed Raul during his journey to Geneva. Through the <\/span>#RaulWHO page<\/span><\/a>, those concerned about the future of CBD could keep up with regular announcements and personal streaming video updates from Raul.<\/span><\/p>\n Raul\u2019s incredible efforts and his influence on the WHO special committee\u2019s recommendation were covered in international media outlets such as the following:<\/span><\/p>\n \u201cWe couldn\u2019t be prouder to have Ra\u00fal representing the Medical Marijuana, Inc. portfolio of companies and to have our mission of increasing access to CBD featured in coverage on such prominent media outlets,\u201d said Medical Marijuana, Inc. CEO Dr. Stuart Titus.<\/span><\/p>\n \u201cWe believe that Ra\u00fal had a significant impact on the World Health Organization\u2019s recommendation not to schedule CBD and we\u2019re thankful that the media continues to view him as an important cannabis industry icon. Medical Marijuana, Inc. continues to be a leader for the industry, and the future is very bright indeed.\u201d<\/span><\/p>\n Read more about CBD through our <\/span>education page<\/span><\/a>, or keep up with <\/span>Medical Marijuana, Inc.<\/span><\/a>\u2019s entire portfolio of companies on our <\/span>news feed<\/span><\/a>.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Following the WHO\u2019s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA\u2019s role in the organization\u2019s decision.Raul Addresses WHO Committee about CBD at United Nations<\/b><\/h2>\n
Raul\u2019s Impact on CBD Decision Garners International News Coverage<\/b><\/h2>\n
\n
Learn More about MJNA and CBD<\/b><\/h2>\n
\nSeveral international news publications covering last week\u2019s World Health Organization announcement of its recommendation that cannabidiol (CBD) not be subject to international drug scheduling specifically highlighted the impact of Medical Marijuana, Inc. Executive Raul Elizalde.<\/p>\n","protected":false},"author":1,"featured_media":221,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[162],"tags":[],"class_list":["post-2247","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media-coverage"],"yoast_head":"\n